NUVB Form 144: Planned sale of 100,000 shares worth $485,000

NUVB filed a Form 144 notice indicating a planned sale of 100,000 common shares.

Rhea-AI Filing Summary

NUVB filed a Form 144 notice indicating a planned sale of 100,000 common shares. The filing lists an aggregate market value of $485,000 and identifies Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004) as the broker. The approximate date of sale is 10/27/2025, and the shares are listed on the NYSE.

The seller acquired the shares on 10/27/2025 through an exercise of stock options from the issuer, with cash as the form of payment. The filing also notes 342,272,722 shares outstanding.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the NUVB Form 144 filing disclose?

A planned sale of 100,000 common shares with an aggregate market value of $485,000.

When is the approximate sale date for the NUVB shares?

The filing lists an approximate sale date of 10/27/2025.

How were the NUVB shares acquired before the planned sale?

They were acquired on 10/27/2025 via an exercise of stock options, paid in cash.

Which broker is handling the NUVB Form 144 sale?

Morgan Stanley Smith Barney LLC (Executive Financial Services, New York).

On which exchange are the NUVB shares listed?

The filing names the NYSE as the securities exchange.

How many NUVB shares are outstanding according to the filing?

The filing notes 342,272,722 shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/27/2025 - 04:26 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001521111
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NUVATION BIO INC
SEC File Number	001-39351
Address of Issuer	1500 Broadway, Suite 1401 New York NEW YORK 10036
Phone	332-208-6102
Name of Person for Whose Account the Securities are To Be Sold	GARY HATTERSLEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	100000	485000.00	342272722	10/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/27/2025	Exercise of Stock Options	Issuer			100000	10/27/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	10/27/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/24/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Hattersley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)